Skip to main content
SpringerLink
Log in

The Role of the Gastrointestinal Microbiota in Visceral Pain

  • Chapter
  • First Online:
Gastrointestinal Pharmacology

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 239))

Abstract

A growing body of preclinical and clinical evidence supports a relationship between the complexity and diversity of the microorganisms that inhabit our gut (human gastrointestinal microbiota) and health status. Under normal homeostatic conditions this microbial population helps maintain intestinal peristalsis, mucosal integrity, pH balance, immune priming and protection against invading pathogens. Furthermore, these microbes can influence centrally regulated emotional behaviour through mechanisms including microbially derived bioactive molecules (amino acid metabolites, short-chain fatty acids, neuropeptides and neurotransmitters), mucosal immune and enteroendocrine cell activation, as well as vagal nerve stimulation.

The microbiota-gut-brain axis comprises a dynamic matrix of tissues and organs including the brain, autonomic nervous system, glands, gut, immune cells and gastrointestinal microbiota that communicate in a complex multidirectional manner to maintain homeostasis and resist perturbation to the system. Changes to the microbial environment, as a consequence of illness, stress or injury, can lead to a broad spectrum of physiological and behavioural effects locally including a decrease in gut barrier integrity, altered gut motility, inflammatory mediator release as well as nociceptive and distension receptor sensitisation. Centrally mediated events including hypothalamic-pituitary-adrenal (HPA) axis, neuroinflammatory events and neurotransmitter systems are concomitantly altered. Thus, both central and peripheral pathways associated with pain manifestation and perception are altered as a consequence of the microbiota-gut-brain axis imbalance.

In this chapter the involvement of the gastrointestinal microbiota in visceral pain is reviewed. We focus on the anatomical and physiological nodes whereby microbiota may be mediating pain response, and address the potential for manipulating gastrointestinal microbiota as a therapeutic target for visceral pain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Leveque M, Keranen H, Theodorou V, Bourdu-Naturel S, Goupil-Feuillerat N, Legrain-Raspaud S, Eutamene H (2012) A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil 24(4):376-e172

    Article  PubMed  Google Scholar 

  • Aguilera M, Cerda-Cuellar M, Martinez V (2015) Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. Gut Microbes 6(1):10–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Akbar A, Walters JR, Ghosh S (2009) Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Aliment Pharmacol Ther 30(5):423–435

    Article  CAS  PubMed  Google Scholar 

  • Allez M, Tieng V, Nakazawa A, Treton X, Pacault V, Dulphy N, Caillat-Zucman S, Paul P, Gornet JM, Douay C, Ravet S, Tamouza R, Charron D, Lemann M, Mayer L, Toubert A (2007) CD4+NKG2D+ T cells in Crohn’s disease mediate inflammatory and cytotoxic responses through MICA interactions. Gastroenterology 132(7):2346–2358

    Article  CAS  PubMed  Google Scholar 

  • Amaral FA, Sachs D, Costa VV, Fagundes CT, Cisalpino D, Cunha TM, Ferreira SH, Cunha FQ, Silva TA, Nicoli JR, Vieira LQ, Souza DG, Teixeira MM (2008) Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A 105(6):2193–2197

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Andrews PJ, Borody TJ (1993) “Putting back the bugs”: bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med J Aust 159(9):633–634

    CAS  PubMed  Google Scholar 

  • Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D (2013) Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 108(10):1620–1630

    Article  CAS  PubMed  Google Scholar 

  • Barbara G, Scaioli E, Barbaro MR, Biagi E, Laghi L, Cremon C, Marasco G, Colecchia A, Picone G, Salfi N, Capozzi F, Brigidi P, Festi D (2016) Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. doi:10.1136/gutjnl-2016-312377

    Google Scholar 

  • Bengmark S (2013) Gut microbiota, immune development and function. Pharmacol Res 69(1):87–113

    Article  CAS  PubMed  Google Scholar 

  • Bennet JD, Brinkman M (1989) Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1(8630):164

    Article  CAS  PubMed  Google Scholar 

  • Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P (2013) Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res 69(1):11–20

    Article  PubMed  Google Scholar 

  • Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D (1989) Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 150(10):604

    CAS  PubMed  Google Scholar 

  • Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF (2014a) The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol 817:373–403

    Article  CAS  PubMed  Google Scholar 

  • Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF (2014b) Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 20(9):509–518

    Article  PubMed  Google Scholar 

  • Boue J, Basso L, Cenac N, Blanpied C, Rolli-Derkinderen M, Neunlist M, Vergnolle N, Dietrich G (2014) Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(+) T cells in mice. Gastroenterology 146(1):166–175

    Article  CAS  PubMed  Google Scholar 

  • Bradesi S (2010) Role of spinal cord glia in the central processing of peripheral pain perception. Neurogastroenterol Motil 22(5):499–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Braundmeier-Fleming A, Russell NT, Yang W, Nas MY, Yaggie RE, Berry M, Bachrach L, Flury SC, Marko DS, Bushell CB, Welge ME, White BA, Schaeffer AJ, Klumpp DJ (2016) Stool-based biomarkers of interstitial cystitis/bladder pain syndrome. Sci Rep 6:26083

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burokas A, Moloney RD, Dinan TG, Cryan JF (2015) Microbiota regulation of the Mammalian gut-brain axis. Adv Appl Microbiol 91:1–62

    Article  PubMed  Google Scholar 

  • Canavan C, West J, Card T (2014) Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 40(9):1023–1034

    Article  CAS  PubMed  Google Scholar 

  • Cani PD, Everard A, Duparc T (2013) Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 13(6):935–940

    Article  CAS  PubMed  Google Scholar 

  • Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 24(6):521–530, e248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cassel SL, Sutterwala FS, Flavell RA (2008) The tiny conductor: immune regulation via commensal organisms. Cell Host Microbe 3(6):340–341

    Article  CAS  PubMed  Google Scholar 

  • Cenac N, Altier C, Chapman K, Liedtke W, Zamponi G, Vergnolle N (2008) Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology 135(3):937–946, 946.e1–2

    Google Scholar 

  • Cenac N, Bautzova T, Le Faouder P, Veldhuis NA, Poole DP, Rolland C, Bertrand J, Liedtke W, Dubourdeau M, Bertrand-Michel J, Zecchi L, Stanghellini V, Bunnett NW, Barbara G, Vergnolle N (2015) Quantification and potential functions of endogenous agonists of transient receptor potential channels in patients with irritable bowel syndrome. Gastroenterology 149(2):433–444.e7

    Article  CAS  PubMed  Google Scholar 

  • Cervero F (2009) Visceral versus somatic pain: similarities and differences. Dig Dis 27(Suppl 1):3–10

    Article  PubMed  Google Scholar 

  • Chang L (2005) Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder? Gastroenterol Clin North Am 34(2):271–279

    Article  PubMed  Google Scholar 

  • Clarke G, Cryan JF, Dinan TG, Quigley EM (2012) Review article: probiotics for the treatment of irritable bowel syndrome – focus on lactic acid bacteria. Aliment Pharmacol Ther 35(4):403–413

    Article  CAS  PubMed  Google Scholar 

  • Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF (2013) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18(6):666–673

    Article  CAS  PubMed  Google Scholar 

  • Collins SM, Surette M, Bercik P (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10(11):735–742

    Article  CAS  PubMed  Google Scholar 

  • Conte MP, Schippa S, Zamboni I, Penta M, Chiarini F, Seganti L, Osborn J, Falconieri P, Borrelli O, Cucchiara S (2006) Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55(12):1760–1767

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cortright DN, Szallasi A (2009) TRP channels and pain. Curr Pharm Des 15(15):1736–1749

    Article  CAS  PubMed  Google Scholar 

  • Crouzet L, Gaultier E, Del’Homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A (2013) The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 25(4):e272–e282

    Article  CAS  PubMed  Google Scholar 

  • Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13(10):701–712

    Article  CAS  PubMed  Google Scholar 

  • Cryan JF, Dinan TG (2015a) Gut microbiota: microbiota and neuroimmune signalling-Metchnikoff to microglia. Nat Rev Gastroenterol Hepatol 12(9):494–496

    Article  PubMed  Google Scholar 

  • Cryan JF, Dinan TG (2015b) More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology 40(1):241–242

    Article  PubMed  Google Scholar 

  • Cummings JH, Macfarlane GT (1997) Role of intestinal bacteria in nutrient metabolism. JPEN J Parenter Enteral Nutr 21(6):357–365

    Article  CAS  PubMed  Google Scholar 

  • Curro D, Ianiro G, Pecere S, Bibbo S, Cammarota G (2016) Probiotics, fiber and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol. doi:10.1111/bph.13632

    PubMed  Google Scholar 

  • Dai C, Guandalini S, Zhao DH, Jiang M (2012) Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function. Mol Cell Biochem 362(1–2):43–53

    Article  CAS  PubMed  Google Scholar 

  • de Weerth C, Fuentes S, de Vos WM (2013) Crying in infants: on the possible role of intestinal microbiota in the development of colic. Gut Microbes 4(5):416–421

    Article  PubMed  PubMed Central  Google Scholar 

  • Dinan TG, Stilling RM, Stanton C, Cryan JF (2015) Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res 63:1–9

    Article  PubMed  Google Scholar 

  • Distrutti E, Cipriani S, Mencarelli A, Renga B, Fiorucci S (2013) Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS One 8(5):e63893

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Duerkop BA, Vaishnava S, Hooper LV (2009) Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31(3):368–376

    Article  CAS  PubMed  Google Scholar 

  • Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638

    Article  PubMed  PubMed Central  Google Scholar 

  • El Aidy S, Dinan TG, Cryan JF (2014) Immune modulation of the brain-gut-microbe axis. Front Microbiol 5:146

    Article  PubMed  PubMed Central  Google Scholar 

  • Erny D, Hrabe de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, Keren-Shaul H, Mahlakoiv T, Jakobshagen K, Buch T, Schwierzeck V, Utermohlen O, Chun E, Garrett WS, McCoy KD, Diefenbach A, Staeheli P, Stecher B, Amit I, Prinz M (2015) Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18(7):965–977

    Article  CAS  PubMed  Google Scholar 

  • Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthesy-Theulaz I, Fioramonti J, Bueno L (2007) Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 137(8):1901–1907

    CAS  PubMed  Google Scholar 

  • Farup PG, Jacobsen M, Ligaarden SC, Rudi K (2012) Probiotics, symptoms, and gut microbiota: what are the relations? A randomized controlled trial in subjects with irritable bowel syndrome. Gastroenterol Res Pract 2012:214102

    PubMed  PubMed Central  Google Scholar 

  • Ford AC (2010) Probiotics in irritable bowel syndrome: underachievers or underpowered? Aliment Pharmacol Ther 31(8):922–923, author reply 923–924

    Article  CAS  PubMed  Google Scholar 

  • Frank DN, Pace NR (2008) Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 24(1):4–10

    Article  CAS  PubMed  Google Scholar 

  • Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF (2007) Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun 21(1):47–59

    Article  CAS  PubMed  Google Scholar 

  • Gaci N, Borrel G, Tottey W, O’Toole PW, Brugere JF (2014) Archaea and the human gut: new beginning of an old story. World J Gastroenterol 20(43):16062–16078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Giannetti E, Maglione M, Alessandrella A, Strisciuglio C, De Giovanni D, Campanozzi A, Miele E, Staiano A (2016) A mixture of 3 Bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial. J Clin Gastroenterol. doi:10.1097/MCG.0000000000000528

    Google Scholar 

  • Greenwood-Van Meerveld B, Prusator DK, Johnson AC (2015) Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol 308(11):G885–G903

    Article  PubMed  CAS  Google Scholar 

  • Guglielmetti S, Mora D, Gschwender M, Popp K (2011) Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life – a double-blind, placebo-controlled study. Aliment Pharmacol Ther 33(10):1123–1132

    Article  CAS  PubMed  Google Scholar 

  • Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146(1):67–75.e5

    Article  CAS  PubMed  Google Scholar 

  • Hoban AE, Moloney RD, Golubeva AV, McVey Neufeld KA, O’Sullivan O, Patterson E, Stanton C, Dinan TG, Clarke G, Cryan JF (2016) Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat. Neuroscience 339:463–477

    Article  CAS  PubMed  Google Scholar 

  • Horvath A, Dziechciarz P, Szajewska H (2011) Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 33(12):1302–1310

    Article  CAS  PubMed  Google Scholar 

  • Hungin AP, Mulligan C, Pot B, Whorwell P, Agreus L, Fracasso P, Lionis C, Mendive J, Philippart de Foy JM, Rubin G, Winchester C, de Wit N (2013) Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide. Aliment Pharmacol Ther 38(8):864–886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Husebye E (1997) Communication between CNS and ENS: do regulatory peptides play a role in control of sleep modulation of gastrointestinal motility? Neurogastroenterol Motil 9(1):1–3

    Article  CAS  PubMed  Google Scholar 

  • Jalanka-Tuovinen J, Salojarvi J, Salonen A, Immonen O, Garsed K, Kelly FM, Zaitoun A, Palva A, Spiller RC, de Vos WM (2014) Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 63(11):1737–1745

    Article  PubMed  Google Scholar 

  • Jeffery IB, O’Toole PW, Ohman L, Claesson MJ, Deane J, Quigley EM, Simren M (2012a) An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61(7):997–1006

    Article  PubMed  Google Scholar 

  • Jeffery IB, Quigley EM, Ohman L, Simren M, O’Toole PW (2012b) The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes 3(6):572–576

    Article  PubMed  PubMed Central  Google Scholar 

  • Johnson AC, Greenwood-Van Meerveld B, McRorie J (2011) Effects of Bifidobacterium infantis 35624 on post-inflammatory visceral hypersensitivity in the rat. Dig Dis Sci 56(11):3179–3186

    Article  PubMed  Google Scholar 

  • Kamada N, Seo SU, Chen GY, Nunez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13(5):321–335

    Article  CAS  PubMed  Google Scholar 

  • Kamiya T, Wang L, Forsythe P, Goettsche G, Mao Y, Wang Y, Tougas G, Bienenstock J (2006) Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 55(2):191–196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kannampalli P, Pochiraju S, Chichlowski M, Berg BM, Rudolph C, Bruckert M, Miranda A, Sengupta JN (2014) Probiotic Lactobacillus rhamnosus GG (LGG) and prebiotic prevent neonatal inflammation-induced visceral hypersensitivity in adult rats. Neurogastroenterol Motil 26(12):1694–1704

    Article  CAS  PubMed  Google Scholar 

  • Kassinen A, Krogius-Kurikka L, Makivuokko H, Rinttila T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133(1):24–33

    Article  CAS  PubMed  Google Scholar 

  • Kasubuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I (2015) Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 7(4):2839–2849

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, Takami H, Morita H, Sharma VK, Srivastava TP, Taylor TD, Noguchi H, Mori H, Ogura Y, Ehrlich DS, Itoh K, Takagi T, Sakaki Y, Hayashi T, Hattori M (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14(4):169–181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Larauche M, Mulak A, Yuan PQ, Kanauchi O, Tache Y (2012) Stress-induced visceral analgesia assessed non-invasively in rats is enhanced by prebiotic diet. World J Gastroenterol 18(3):225–236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Laval L, Martin R, Natividad JN, Chain F, Miquel S, Desclee de Maredsous C, Capronnier S, Sokol H, Verdu EF, van Hylckama Vlieg JE, Bermudez-Humaran LG, Smokvina T, Langella P (2015) Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice. Gut Microbes 6(1):1–9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee KJ, Tack J (2010) Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil 22(5):493–498

    Article  CAS  PubMed  Google Scholar 

  • Lyte M (2013) Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog 9(11):e1003726

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lyte M (2014) Microbial endocrinology and the microbiota-gut-brain axis. Adv Exp Med Biol 817:3–24

    Article  CAS  PubMed  Google Scholar 

  • Malinen E, Krogius-Kurikka L, Lyra A, Nikkila J, Jaaskelainen A, Rinttila T, Vilpponen-Salmela T, von Wright AJ, Palva A (2010) Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 16(36):4532–4540

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J (2006) Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55(2):205–211

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Martin R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama VJ, Bermudez-Humaran LG, Smokvina T, Langella P (2016) Bifidobacterium animalis ssp. lactis CNCM-I2494 restores gut barrier permeability in chronically low-grade inflamed mice. Front Microbiol 7:608

    PubMed  PubMed Central  Google Scholar 

  • Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, Saarela M (2005) Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome – a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43(2):213–222

    Article  PubMed  CAS  Google Scholar 

  • Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K (2014a) Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34(46):15490–15496

    Article  PubMed  PubMed Central  Google Scholar 

  • Mayer EA, Savidge T, Shulman RJ (2014b) Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology 146(6):1500–1512

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mayer EA, Gupta A, Kilpatrick LA, Hong JY (2015a) Imaging brain mechanisms in chronic visceral pain. Pain 156(Suppl 1):S50–S63

    Article  PubMed  PubMed Central  Google Scholar 

  • Mayer EA, Tillisch K, Gupta A (2015b) Gut/brain axis and the microbiota. J Clin Invest 125(3):926–938

    Article  PubMed  PubMed Central  Google Scholar 

  • Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107–118

    Article  CAS  PubMed  Google Scholar 

  • McKernan DP, Fitzgerald P, Dinan TG, Cryan JF (2010) The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 22(9):1029–1035, e268

    Article  CAS  PubMed  Google Scholar 

  • Michail S, Kenche H (2011) Gut microbiota is not modified by randomized, double-blind, placebo-controlled trial of VSL#3 in diarrhea-predominant irritable bowel syndrome. Probiotics Antimicrob Proteins 3(1):1–7

    Article  PubMed  PubMed Central  Google Scholar 

  • Millan MJ (1999) The induction of pain: an integrative review. Prog Neurobiol 57(1):1–164

    Article  CAS  PubMed  Google Scholar 

  • Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Ford AC (2014) The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 109(9):1367–1374

    Article  CAS  PubMed  Google Scholar 

  • Moloney RD, Desbonnet L, Clarke G, Dinan TG, Cryan JF (2014) The microbiome: stress, health and disease. Mamm Genome 25(1–2):49–74

    Article  CAS  PubMed  Google Scholar 

  • Moloney RD, O’Mahony SM, Dinan TG, Cryan JF (2015) Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psych 6:15

    Google Scholar 

  • Moloney RD, Johnson AC, O’Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF (2016) Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neurosci Ther 22(2):102–117

    Article  PubMed  Google Scholar 

  • Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6:392

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A (2010) Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 10:134

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • O’Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O’Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128(3):541–551

    Article  PubMed  Google Scholar 

  • O’Mahony SM, Tramullas M, Fitzgerald P, Cryan JF (2012) Rodent models of colorectal distension. Curr Protoc Neurosci Chapter 9:Unit 9.40

    Google Scholar 

  • O’Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F, Quigley EM, Marchesi JR, O’Toole PW, Dinan TG, Cryan JF (2014) Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 277:885–901

    Article  PubMed  CAS  Google Scholar 

  • Olesen M, Gudmand-Hoyer E (2000) Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 72(6):1570–1575

    CAS  PubMed  Google Scholar 

  • Oleskin AV, Shenderov BA (2016) Neuromodulatory effects and targets of the SCFAs and gasotransmitters produced by the human symbiotic microbiota. Microb Ecol Health Dis 27:30971

    PubMed  Google Scholar 

  • Partty A, Luoto R, Kalliomaki M, Salminen S, Isolauri E (2013) Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J Pediatr 163(5):1272–1277.e1–2

    Google Scholar 

  • Pimentel M (2016) Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther 43(Suppl 1):37–49

    Article  CAS  PubMed  Google Scholar 

  • Pimentel M, Morales W, Chua K, Barlow G, Weitsman S, Kim G, Amichai MM, Pokkunuri V, Rook E, Mathur R, Marsh Z (2011) Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects. Dig Dis Sci 56(7):2067–2072

    Article  CAS  PubMed  Google Scholar 

  • Pinn DM, Aroniadis OC, Brandt LJ (2015) Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterol Motil 27(1):19–29

    Article  CAS  PubMed  Google Scholar 

  • Pott J, Hornef M (2012) Innate immune signalling at the intestinal epithelium in homeostasis and disease. EMBO Rep 13(8):684–698

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141(5):1792–1801

    Article  CAS  PubMed  Google Scholar 

  • Rea K, Dinan TG, Cryan JF (2016) The microbiome: a key regulator of stress and neuroinflammation. Neurobiol Stress 4:23–33

    Article  PubMed  PubMed Central  Google Scholar 

  • Rhee SH, Pothoulakis C, Mayer EA (2009) Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6(5):306–314

    Article  CAS  PubMed  Google Scholar 

  • Ringel-Kulka T, Goldsmith JR, Carroll IM, Barros SP, Palsson O, Jobin C, Ringel Y (2014) Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain – a randomised clinical study. Aliment Pharmacol Ther 40(2):200–207

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ringel-Kulka T, Benson AK, Carroll IM, Kim J, Legge RM, Ringel Y (2016) Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol 310(6):G417–G426

    Article  PubMed  Google Scholar 

  • Rosenbaum T, Simon SA (2007) TRPV1 receptors and signal transduction. In: Liedtke WB, Heller S (eds) TRP ion channel function in sensory transduction and cellular signaling cascades. CRC Press/Taylor & Francis, Boca Raton

    Google Scholar 

  • Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Royet J, Gupta D, Dziarski R (2011) Peptidoglycan recognition proteins: modulators of the microbiome and inflammation. Nat Rev Immunol 11(12):837–851

    CAS  PubMed  Google Scholar 

  • Russell WR, Hoyles L, Flint HJ, Dumas ME (2013) Colonic bacterial metabolites and human health. Curr Opin Microbiol 16(3):246–254

    Article  CAS  PubMed  Google Scholar 

  • Saab CY, Wang J, Gu C, Garner KN, Al-Chaer ED (2006) Microglia: a newly discovered role in visceral hypersensitivity? Neuron Glia Biol 2(4):271–277

    Article  PubMed  Google Scholar 

  • Sachdev AH, Pimentel M (2012) Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep 14(5):439–445

    Article  PubMed  Google Scholar 

  • Sampson TR, Mazmanian SK (2015) Control of brain development, function, and behavior by the microbiome. Cell Host Microbe 17(5):565–576

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saulnier DM, Riehle K, Mistretta TA, Diaz MA, Mandal D, Raza S, Weidler EM, Qin X, Coarfa C, Milosavljevic A, Petrosino JF, Highlander S, Gibbs R, Lynch SV, Shulman RJ, Versalovic J (2011) Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 141(5):1782–1791

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, Roana J, Silvestro L, Oggero R (2004) Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatr 93(6):825–829

    Article  CAS  PubMed  Google Scholar 

  • Savino F, Pelle E, Palumeri E, Oggero R, Miniero R (2007) Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics 119(1):e124–e130

    Article  PubMed  Google Scholar 

  • Scarpellini E, Ianiro G, Attili F, Bassanelli C, De Santis A, Gasbarrini A (2015) The human gut microbiota and virome: potential therapeutic implications. Dig Liver Dis 47(12):1007–1012

    Article  PubMed  Google Scholar 

  • Schafer DP, Stevens B (2015) Microglia function in central nervous system development and plasticity. Cold Spring Harb Perspect Biol 7(10):a020545

    Article  PubMed  CAS  Google Scholar 

  • Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B (2012) Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74(4):691–705

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shankar V, Homer D, Rigsbee L, Khamis HJ, Michail S, Raymer M, Reo NV, Paliy O (2015) The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome. ISME J 9(8):1899–1903

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009) Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29(5):508–518

    Article  CAS  PubMed  Google Scholar 

  • Simren M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG, Rome Foundation C (2013) Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 62(1):159–176

    Article  PubMed  Google Scholar 

  • Sisson G, Ayis S, Sherwood RA, Bjarnason I (2014) Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome – a 12 week double-blind study. Aliment Pharmacol Ther 40(1):51–62

    Article  CAS  PubMed  Google Scholar 

  • Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, Teixeira MM (2004) The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 173(6):4137–4146

    Article  CAS  PubMed  Google Scholar 

  • Stilling RM, Dinan TG, Cryan JF (2014) Microbial genes, brain & behaviour – epigenetic regulation of the gut-brain axis. Genes Brain Behav 13(1):69–86

    Article  CAS  PubMed  Google Scholar 

  • Stilling RM, van de Wouw M, Clarke G, Stanton C, Dinan TG, Cryan JF (2016) The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis? Neurochem Int 99:110–132

    Article  CAS  PubMed  Google Scholar 

  • Sudo N (2012) Role of microbiome in regulating the HPA axis and its relevance to allergy. Chem Immunol Allergy 98:163–175

    Article  CAS  PubMed  Google Scholar 

  • Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y (2004) Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558(Pt 1):263–275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Takeda K, Akira S (2004) Microbial recognition by Toll-like receptors. J Dermatol Sci 34(2):73–82

    Article  CAS  PubMed  Google Scholar 

  • Thabane M, Kottachchi DT, Marshall JK (2007) Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 26(4):535–544

    Article  CAS  PubMed  Google Scholar 

  • Vaishnava S, Behrendt CL, Hooper LV (2008a) Innate immune responses to commensal bacteria in the gut epithelium. J Pediatr Gastroenterol Nutr 46(Suppl 1):E10–E11

    PubMed  Google Scholar 

  • Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV (2008b) Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A 105(52):20858–20863

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Verdu EF, Bercik P, Verma-Gandhu M, Huang XX, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM (2006) Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 55(2):182–190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vergnolle N (2009) Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Ther 123(3):292–309

    Article  CAS  PubMed  Google Scholar 

  • Whelan K (2011) Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 14(6):581–587

    Article  PubMed  Google Scholar 

  • Williamson LL, McKenney EA, Holzknecht ZE, Belliveau C, Rawls JF, Poulton S, Parker W, Bilbo SD (2016) Got worms? Perinatal exposure to helminths prevents persistent immune sensitization and cognitive dysfunction induced by early-life infection. Brain Behav Immun 51:14–28

    Article  CAS  PubMed  Google Scholar 

  • Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG (2014) Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. J Gastroenterol Hepatol 29(1):52–59

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. APC Microbiome Institute, University College Cork, Cork, Ireland

    Kieran Rea, Siobhain M. O’Mahony, Timothy G. Dinan & John F. Cryan

  2. Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland

    Siobhain M. O’Mahony & John F. Cryan

  3. Department of Psychiatry and Neurobehavioural Science, University College Cork, Cork, Ireland

    Timothy G. Dinan

Authors
  1. Kieran Rea
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siobhain M. O’Mahony
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy G. Dinan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John F. Cryan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John F. Cryan .

Editor information

Editors and Affiliations

  1. Health Sciences Center, The University of Oklahoma, Oklahoma City, Oklahoma, USA

    Beverley Greenwood-Van Meerveld

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Rea, K., O’Mahony, S.M., Dinan, T.G., Cryan, J.F. (2017). The Role of the Gastrointestinal Microbiota in Visceral Pain. In: Greenwood-Van Meerveld, B. (eds) Gastrointestinal Pharmacology . Handbook of Experimental Pharmacology, vol 239. Springer, Cham. https://doi.org/10.1007/164_2016_115

Download citation

Publish with us

Policies and ethics

Search

Navigation